Pfizer bolstered its fiscal targets after generating $16.58 billion in third-quarter revenue, comfortably surpassing analyst estimates compiled by LSEG. Adjusted earnings reached 87 cents per share, which also topped market expectations by 14 cents. Alongside the raised profit and revenue targets, the firm formalized long-time finance executive Cecile Guegan as its permanent chief financial officer. Guegan had already been handling executive duties on an interim basis following the departure of her predecessor.
Key points
The updated full-year adjusted profit forecast now sits at $2.95 to $3.05 per share.: The updated full-year adjusted profit forecast now sits at $2.95 to $3.05 per share.
The low end of the new revenue guidance reflects essentially flat performance against pre…: The low end of the new revenue guidance reflects essentially flat performance against previous annual totals.
Cecile Guegan officially assumed the chief financial officer role after serving as interi…: Cecile Guegan officially assumed the chief financial officer role after serving as interim head since August.
Sources checked by our analysis pipeline: 1
Pfizer on Tuesday reported third-quarter results that topped estimates and hiked its full-year outlook, citing its "strong year-to-date performance" and ongoing cost cuts.
Pfizer also Tuesday announced that Cecile Guegan, who has held various finance leadership roles at the company over the last two decades, stepped in as chief financial officer this month. She had served as interim CFO since August, when Pfizer's former CFO, Dave Denton, stepped down to take the same position at Nike.
The company is now expecting full-year revenue to total $62 billion to $64 billion, which compares to a previous outlook of $60.5 billion to $62.5 billion. The low end of that sales range would be roughly flat or down slightly compared with 2025 revenue of $62.6 billion.
The pharmaceutical giant now expects full-year adjusted profit of between $2.95 and $3.05 per share. That compares with a previous guidance of between $2.80 and $3 per share.
Here's what the company reported for the third quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG:
The legal battle reflects escalating internal conflict between the Dutch semiconductor manufacturer and its controlling Chinese shareholder. Accusing leadership of detrimental conduct, the firm is seeking formal financial restitution for harm inflicted on its ongoing commercial operations. The dispute now moves to European jurisdiction for judicial resolution.
The Indian automotive group has finalized a massive multibillion-euro buyout in Europe, securing a controlling stake that integrates extensive manufacturing networks across multiple continents. This consolidation drastically scales global operations and creates an automotive powerhouse generating combined revenues of roughly 21 billion euros. It represents the conglomerate's most significant cross-border purchase since acquiring British luxury brands over a decade ago.
Strong financial execution allowed the energy company to exceed Wall Street projections for the recent quarter. Alongside the operational outperformance, management decided to offload a pair of refining assets directly to CVR Energy to rebalance its portfolio. The combined maneuvers underscore an active push to streamline operations while capitalizing on positive momentum.